Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H2 | P55055 | 3/20 | 0.40 |
| ▸ | NR1H3 | Q13133 | 3/20 | 0.40 |
| ▸ | RORC | P51449 | 2/20 | 0.39 |
| ▸ | FPR2 | P25090 | 5/20 | 0.34 |
| ▸ | FPR3 | P25089 | 4/20 | 0.34 |
| ▸ | XIAP | P98170 | 3/20 | 0.31 |
| ▸ | BIRC2 | Q13490 | 3/20 | 0.31 |
| ▸ | SETD7 | Q8WTS6 | 1/20 | 0.31 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.31 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.31 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25328285 | 0.92 | NR1H2 (0.46) | NR1H2NR1H3RORCFPR2FPR3 | |
| SCHEMBL25328288 | 0.92 | NR1H2 (0.46) | NR1H2NR1H3RORCFPR2FPR3 | |
| SCHEMBL30522902 | 0.91 | RORC (0.36) | NR1H2NR1H3RORCGPR119 | |
| SCHEMBL30522976 | 0.89 | NR1H2 (0.39) | NR1H2NR1H3RORCFPR2FPR3 | |
| SCHEMBL25326018 | 0.86 | NR1H2 (0.47) | NR1H2NR1H3RORCFPR2FPR3 | |
| SCHEMBL25326015 | 0.86 | NR1H2 (0.47) | NR1H2NR1H3RORCFPR2FPR3 | |
| SCHEMBL30523044 | 0.85 | NR1H2 (0.41) | NR1H2NR1H3RORCFPR2FPR3 | |
| SCHEMBL30522972 | 0.82 | NR1H2 (0.47) | NR1H2NR1H3RORCFPR2FPR3 | |
| SCHEMBL25326809 | 0.81 | RORC (0.41) | NR1H2NR1H3RORCGPR119 | |
| SCHEMBL25327901 | 0.81 | RORC (0.41) | NR1H2NR1H3RORCGPR119 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4469445-A1 | COMPOUNDS AND METHODS OF USE | Tango Therapeutics, Inc. (US) | 2024-12-04 | — | — | EP | disclosed |